Circulation
Summary of the 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease as they relate to Marfan Syndrome, Loeys-Dietz Syndrome, vascular Ehlers-Danlos syndrome (vEDS), ACTA2, PRKG1, MYH11, MYLK, and LOX
- Isselbacher EM, Preventza O, Hamilton Black J 3rd, Augoustides JG, Beck AW, Bolen MA, Braverman AC, Bray BE, Brown-Zimmerman MM, Chen EP, Collins TJ, DeAnda A Jr, Fanola CL, Girardi LN, Hicks CW, Hui DS, Schuyler Jones W, Kalahasti V, Kim KM, Milewicz DM, Oderich GS, Ogbechie L, Promes SB, Gyang Ross E, Schermerhorn ML, Singleton Times S, Tseng EE, Wang GJ, Woo YJ; Peer Review Committee Members. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Dec 13;146(24):e334-e482. doi: 10.1161/CIR.0000000000001106. Epub 2022 Nov 2. PMID: 36322642; PMCID: PMC9876736.
Summary of the 2022 ACC/AHA Guideline as they relate to Marfan Syndrome
Summary of the 2022 ACC/AHA Guideline as they relate to Loeys-Dietz Syndrome
Summary of the 2022 ACC/AHA Guideline as they relate to vascular Ehlers-Danlos syndrome (vEDS)
Summary of the 2022 ACC/AHA Guideline as they relate to ACTA2
Summary of the 2022 ACC/AHA Guideline as they relate to PRKG1, MYH11, MYLK and LOX